Citation: R. Sharifi et al., LEUPROLIDE ACETATE (30-MG DEPOT EVERY 4 MONTHS) IN THE TREATMENT OF ADVANCED PROSTATE-CANCER, Urology, 51(2), 1998, pp. 271-276
Citation: Ld. Knoll et Jh. Abrams, EVALUATION OF PENILE ULTRASONIC VELOCITOMETRY VERSUS PENILE DUPLEX ULTRASONOGRAPHY TO ASSESS PENILE ARTERIAL HEMODYNAMICS, Urology, 51(1), 1998, pp. 89-93
Citation: Ld. Knoll, THE USE OF NOCTURNAL ELECTROBIOIMPEDANCE VOLUMETRIC ASSESSMENT (NEVA)TO EVALUATE ERECTILE FUNCTION, The Journal of urology, 159(5), 1998, pp. 117-117
Authors:
SUSSET JG
GLEASON DM
WHITE CF
MUNOZ D
GITTLEMAN MC
WACHS BH
BROWN JS
KNOLL LD
FRIEDLANDER GS
NAIR VK
Citation: Jg. Susset et al., OPEN-LABEL SAFETY AND DOSE CONVERSION DETERMINATION OF ONCE-DAILY OROS(C) OXYBUTYNIN CHLORIDE FOR URGE URINARY-INCONTINENCE (U-UI)/, The Journal of urology, 159(5), 1998, pp. 139-139
Citation: Ld. Knoll et al., TREATMENT OF PENILE FIBROSIS WITH PROSTHETIC IMPLANTATION AND FLAP ADVANCEMENT WITH TISSUE DEBULKING, The Journal of urology, 156(2), 1996, pp. 394-397
Citation: Ld. Knoll et al., A RANDOMIZED CROSSOVER STUDY USING YOHIMBINE AND ISOXSUPRINE VERSUS PENTOXIFYLLINE IN THE MANAGEMENT OF VASCULOGENIC IMPOTENCE, The Journal of urology, 155(1), 1996, pp. 144-146
Citation: Ld. Knoll et al., MANAGEMENT OF NONDILATABLE CAVERNOUS FIBROSIS WITH THE USE OF A DOWNSIZED INFLATABLE PENILE PROSTHESIS, The Journal of urology, 153(2), 1995, pp. 366-367
Authors:
KNOLL LD
BENSON RC
FURLOW WL
LEE IK
SPANGLER W
Citation: Ld. Knoll et al., INFLATABLE CAVERNOSAL BODY DEVICE - FEASIBILITY AND ACUTE SAFETY STUDY IN THE CANINE MODEL, Urology, 44(1), 1994, pp. 143-148